Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Ebiomedicine|September 20, 2025
Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chainBadrieh Fazeli, Sara Botzenhardt, Franziska Bachhuber, et al.Neurology. Genetics|October 27, 2025
Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora DiseaseLorenzo Muccioli, Bazile Ganceviciute, Felicitas Becker, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 5, 2026
Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvementPaula Klassen, Christoforos Alexudis, Veronika Klose, et al.Neurology and Therapy|March 9, 2026
Divergent Immunological and Neurotrophic Responses to CD20 Depletion in Relapsing and Progressive Multiple SclerosisGudrun M Körner, Thiemo M Möllenkamp, Konstantin F Jendretzky, et al.Journal of Neurology|July 25, 2025
Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseasesSteffen Halbgebauer, Veronika Klose, Badrieh Fazeli, et al.Annals of Neurology|August 23, 2024
Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral SclerosisSimon Witzel, André Huss, Gabriele Nagel, et al.Journal of Neurology|August 14, 2024
Clinical characterization of common pathogenic variants of SOD1-ALS in GermanyMaximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.European Journal of Neurology|January 30, 2026
Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple SclerosisNicolás Fissolo, Pascal Benkert, Andreu Vilaseca-Jolonch, et al.Brain Communications|November 3, 2025
Deep clinical, genetic, and serum biomarker profiling indicates glial and neuronal pathology in primary brain calcificationJanine Schwahn, Sophie Hebestreit, Olivia Kosche, et al.Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2024
Association of Complement Factors With Disability Progression in Primary Progressive Multiple SclerosisJan D Lunemann, Harald Hegen, Luisa María Villar, et al.Pageof 3